ArticleBone marrow transplantation2026

Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial.

R Van Dijck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.